Biologic Resurfacing, Open Debridement, and Capsular Release
We are unable to recommend for or against open debridement and/or non-prosthetic or biologic interposition arthroplasty in patients with glenohumeral joint osteoarthritis. These treatments include: Allograft, Biologic and Interpositional Grafts, Autograft.
Rationale
There is a concern for performing shoulder arthroplasty in younger patients because of potential risk of increased prosthetic loosening and decreased survival of the prosthesis. The role for open debridement and non-prosthetic and /or interposition arthroplasty in the treatment algorithm for osteoarthritis of the glenohumeral joint is inconclusive. Despite an exhaustive review of literature, there was insufficient evidence to make conclusions either in favor or against the efficacy of open debridement and non-prosthetic and /or interposition arthroplasty, including osteoarticular allograft, interpositional soft tissue allograft, and autograft in the treatment of the glenohumeral arthritis of the shoulder.